Baptist Health-Fort Smith introduces the ion robot to enhance early lung cancer detection in the River Valley.
The FDA is evaluating a new drug application for taletrectinib in patients with ROS1 fusion–positive non–small cell lung ...
Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...
Clinical Trials Arena on MSN9h
FDA clears CureVac’s IND application for Phase I lung cancer trialThe US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...
A new study in England shows a strong link between higher rates of chest x-ray referrals in general practice patients with symptoms, such as persistent cough, and earlier lung cancer diagnoses, along ...
The province’s health minister says P.E.I. is getting a lung cancer screening program, something advocates have said is ...
Early detection is the key to surviving lung cancer, but Oklahomans rank 44th out of 47 states in early-stage diagnosis ...
The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...
As a result, anyone who was employed at the test site before its closure in the early 1990s is encouraged to check their ...
5d
A study looked at young people and children living in communities that received less government investment due to the ...
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback